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Abstract
Background: Maslinic acid, a pentacyclic triterpene found in the protective wax-like coating of the leaves and fruit
of Olea europaea L., is a promising agent for the prevention of colon cancer. We have shown elsewhere that
maslinic acid inhibits cell proliferation to a significant extent and activates mitochondrial apoptosis in colon cancer
cells. In our latest work we have investigated further this compound’s apoptotic molecular mechanism.
Methods: We used HT29 adenocarcinoma cells. Changes genotoxicity were analyzed by single-cell gel
electrophoresis (comet assay). The cell cycle was determined by flow cytometry. Finally, changes in protein
expression were examined by western blotting. Student’s t-test was used for statistical comparison.
Results: HT29 cells treated with maslinic acid showed significant increases in genotoxicity and cell-cycle arrest
during the G0/G1 phase after 72 hours’ treatment and an apoptotic sub-G0/G1 peak after 96 hours. Nevertheless,
the molecular mechanism for this cytotoxic effect of maslinic acid has never been properly explored. We show
here that the anti-tumoral activity of maslinic acid might proceed via p53-mediated apoptosis by acting upon the
main signaling components that lead to an increase in p53 activity and the induction of the rest of the factors that
participate in the apoptotic pathway. We found that in HT29 cells maslinic acid activated the expression of c-Jun
NH2-terminal kinase (JNK), thus inducing p53. Treatment of tumor cells with maslinic acid also resulted in an
increase in the expression of Bid and Bax, repression of Bcl-2, release of cytochrome-c and an increase in the
expression of caspases -9, -3, and -7. Moreover, maslinic acid produced belated caspase-8 activity, thus amplifying
the initial mitochondrial apoptotic signaling.
Conclusion: All these results suggest that maslinic acid induces apoptosis in human HT29 colon-cancer cells
through the JNK-Bid-mediated mitochondrial apoptotic pathway via the activation of p53. Thus we propose a
plausible sequential molecular mechanism for the expression of the different proteins responsible for the intrinsic
mitochondrial apoptotic pathway. Further studies with other cell lines will be needed to confirm the general
nature of these findings.
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The activation of apoptotic pathways is a key mechan-
ism by which anticancer drugs kill tumor cells [1,2].
Anticancer drugs normally induce apoptosis signaling
via two major pathways: the mitochondrial or intrinsic
pathway, and the death-receptor or extrinsic pathway.
T h ei n t r i n s i cp a t h w a yi n v o l v e st h er e l e a s eo fp r o - a p o p -
totic factors such as cytochrome-c from the mitochon-
dria, which activate the apoptotic mechanism by
interacting with Apaf-1 and stimulating the initiator cas-
pase-9, which in turn induces proteolytically the activity
of executor caspase-3, one of the principle proteases
participating in the execution phase of apoptosis.
In the extrinsic pathway, activation of the death recep-
tor stimulates the activation of the initiator caspase-8,
which then triggers downstream events either by directly
activating caspase-3 or by cleaving the Bid factor, which
in turn initiates the mitochondrial pathway. Neverthe-
less, Bid has also been seen to be activated by JNK [3,4].
Bid-active targets the mitochondria to modulate other
Bcl-2-like factors such as Bax [5]. It is not clear, how-
ever, whether Bid is the only target of pro-apoptotic
JNK signaling. Death caused by over-expressed MKK7-
JNK proteins has in fact been shown to require the Bax-
like factor of the Bcl-2 group [6]. Furthermore, JNK
may act directly upon the Bcl-2 protein family, thus
inducing the mitochondrial pathway. JNK phosphory-
lates members of the Bcl-2 family of proteins, such as
Bcl-2, and inactivates their apoptotic function [7]. More-
over, the expression of constitutively active JNK (using
the fusion protein MKK7-JNK1) efficiently induces
apoptosis in wild-type cells but not in cells lacking the
pro-apoptotic Bcl-2 family member, such as Bax [6].
The activation of JNK has been described as being
necessary for the induction of apoptosis in different cell
types [6,8].
Apart from this, JNK also phosphorylates and regu-
lates the activity of transcription factors such as p53
[9,10]. It has also been reported that in response to UV,
c-Jun (the principal target of JNK) inhibits p53-mediated
cell-cycle arrest, thereby promoting p53-mediated apop-
tosis [11]. It is well known that c-Jun functions as a
direct repressor of p53 gene transcription [12]. In addi-
tion, it activates at least two proteins in the intrinsic
pathway, including Bax and the p53 apoptosis-inducing
factor. In human leukemia cells, different anticancer
drugs increase p53 phosphorylation and the induction of
JNK pathways [13].
Several mechanisms for the induction of apoptosis by
p53 have been identified, involving both the transcrip-
tional and/or non-transcriptional regulation of its down-
stream effectors. For example, p53 induces apoptosis by
transcriptional up-regulation of pro-apoptotic genes
such as Bax, and by transcriptional repression of anti-
apoptotic Bcl-2 [14]. It has also been found that p53
translocates to mitochondria before the release of cyto-
chrome-c and the activation of pro-caspase-3 [15]. It is
also reported to induce apoptosis via physical interac-
tion with the anti-apoptotic proteins Bcl-2 and Bcl-xL at
their DNA-binding domains, thus leading to the seques-
tration of these proteins from their interaction with pro-
apoptotic partners such as Bax/Bak proteins, which as a
result may form oligomers and permeabilize the outer
mitochondrial membrane, thereby causing the release of
mitochondrial cytochrome-c into the cytosol [16].
The natural triterpenoid maslinic acid (MA) is the
main component (80%) of the protective wax-like coat-
ing of olives. It has anti-oxidant, anti-inflammatory and
anti-tumoral properties [17,18]. We have recently
described the effects of these properties [19] but until
now the precise mechanism for its activity had not been
determined. The participation of JNK in triterpene-
induced apoptosis has been reported previously. For
example, CDDO activates JNK in U-937 leukemia cells
[20] and the same authors obtained similar results with
CDDO imidazolide ester and CDDO methyl ester.
CDDO-Me induces apoptosis via JNK-mediated DR up-
regulation in human lung-cancer cells [21]. The stimula-
tion of JNK, activation of caspase-8, loss of mitochon-
drial transmembrane potential, release of cytochrome-c
and cleavage of caspase-3 have all been described in tri-
terpene-induced apoptosis [22].
We describe here the genotoxicity induced by MA as
observed by comet assays, in which chromatin integrity
is quantified at the level of single cells. We also evalu-
ated apoptosis induction and cell-cycle arrest. Finally,
we determined the probable molecular mechanism via
which MA induces its cytotoxic effects in HT29 cells. In
this way have seen how maslinic acid activates p53 and
thus helps to trigger apoptosis. We determined how, in
HT29, MA activates MAP kinases, including JNKs and
thus p53, by which means they increase their functional
activity. We further found that MA’sc a p a c i t yt ot r i g g e r
apoptosis depends upon JNK and p53 via the induction
of Bax, the inhibition of Bcl-2, the release of cyto-
chrome-c, the activation of caspase-9 and finally that of
caspases -3, -7 and -8. Further studies with different
colon-cancer cell lines will be needed to validate the
general nature of the proposed mechanism.
Methods
Materials
Dulbecco’s modified Eagle’s medium (DMEM), bisbenzi-
mide (Hoechst 33258), low-melting-point agarose
(LMP), high-melting-point agarose (HMP), phosphate-
buffered saline (PBS) and propidium iodide (PI) were
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(FCS) and penicillin/streptomycin were from Gibco-BRL
(Germany). 4’,6-diamidino-2-phenylindole (DAPI) was
from Molecular Probes (Invitrogene, Eugene, USA). Pri-
mary antibodies, anti-caspase-3, -9 and anti-JNK were
from Cell Signaling Technology (USA). Anti-caspase-7,
-8 and anti-Bid were from Biosciences, Belgium. Anti-
p53 was from Calbiochem (Germany). Anti-Bax, anti-
Bcl-2, anti-cytochrome-c and secondary antibodies were
from Santa Cruz Biotechnology (California, USA). All
other reagents were of analytical grade.
Drugs and cells
Maslinic acid is a triterpene derivate from pressed
olives. Its molecular weight is 472.7 g/mol. The extract
used was a powder comprising 98% maslinic acid and
2% oleanolic acid, which is stable when stored at 4°C. It
was dissolved before use at 10 mg/mL in 25% DMSO
and 75% PBS. A stock solution was frozen and stored at
-20°C. Prior to experiments this solution was diluted in
cell-culture medium. All experiments were conducted at
IC50 = 61 ± 1 µM and IC80 = 76 ± 1µM, the values of
MA concentrations required for 50% and 80% growth
inhibition after 72 hours’ treatment [18]. Human color-
ectal adenocarcinoma cell line HT29 (ECACC no.
91072701) was cultured in DMEN medium supplemen-
ted with 2 mM glutamine, 10% heat-inactivated FCS,
10,000 units/mL penicillin and 10 mg/mL streptomycin.
Subconfluent monolayers of cells were used in all
experiments.
Single-cell gel electrophoresis (comet assay)
We adapted the single-cell gel-electrophoresis assay to
assess DNA integrity. The technique, commonly known
as the comet assay, is a sensitive way of measuring DNA
single-strand breaks at the level of single cells. Cells
were suspended in 160 µL of 0.5% LMP in PBS at 37°C
and pipetted onto a frosted-glass microscope slide pre-
coated with 1% HMP in PBS. The agarose was allowed
to set in a thin layer on the microscope slide by protect-
ing it with a coverslip at 4°C for 10 min. The slides were
then immersed in a lysis solution (1% Triton X-100, 2.5
M NaCl, 0.1 M EDTA, and 10 mM Tris 1% lauryl sul-
phate, pH 10.0) at 4°C for 1 h to remove any proteinac-
eous materials while leaving “nucleoids”, i.e. supercoiled
DNA that is morphologically similar to that found in
intact cell nuclei. After lysis the slides were placed in a
wide horizontal electrophoresis tank containing 0.3 M
NaOH and 1 mM EDTA at 4°C for 20 min to promote
the unwinding of DNA at damaged sites before electro-
phoresis. During alkaline electrophoresis at 25 v for 30
min, DNA was attracted to the anode; segments of
unwound DNA were free to migrate, extending from
the nucleoid head to form the tail of a comet-like
image. After being washed with buffer (0.4 M Tris-HCl,
pH 7.5) the slides were stained for 15 min with DAPI to
detect DNA single-strand breaks. Assessments were
made using a fluorescence microscope equipped with an
excitation filter of 450-490 nm. Tail moment values
were quantified by computational scoring of 100 ran-
domly selected comets per gel [23].
Flow cytometric analysis
Flow cytometry is used as a diagnostic tool to measure
DNA ploidy as well as to measure alterations in cell
cycle profiles characteristic of DNA fragmentation
(necrosis) compared to patterned DNA cleavage (apop-
tosis). The information obtained includes the visualiza-
tion of cell subpopulations with differing DNA contents.
For each nucleus subpopulation identified, the para-
meters of population size, fractions of nuclei in each
phase of the cell cycle and computation of DNA ratios
can be discerned. DNA hypoploid changes are charac-
teristic of apoptosis. Cells seeded at a density of 175 ×
103 HT29 cells/well were plated in 6-well plates with 2
mL of medium. After 24 h the cells were treated with
different doses of MA for 72 or 96 h. The cells were
resuspended by trypsinization and washed in PBS. The
cells (6 × 105) were fixed in ice-cold ethanol (70%) for
30 min. The total DNA content was stained with 1 mg/
mL PI. The number of cells at each stage of the cell
cycle was estimated by fluorescence-associated cell sort-
ing (FACS) and monitored by flow cytometry. The cell
cycle was analyzed using Multicycle software. The data
were analyzed to determine the percentage of cells at
each phase of the cell cycle (G0/G1, S and G2/M) or in
aneuploid peak.
Cytosolic extracts for cytochrome-c analysis
HT29 cells (1.2 × 106) were cultured in 100-mm plates
and treated for 48 and 72 h with MA at concentrations
of IC50 and IC80. After treatment the cells were washed
with ice-cold PBS and resuspended in ice-cold lysis buf-
fer (20 mM HEPES, pH 7.5, 10 mM KCl, 1.5 mM
MgCl2, 1 mM EDTA, 1 mM EGTA, 250 mM sucrose, 1
mM dithiothreitol, 0.1 mM phenyl methylsulfonyl fluor-
ide, 1 μg/mL pepstatin A, 2 μg/mL leupeptin and 10 μg/
mL aprotinine). After incubation on ice for 30 min the
cells were homogenized with 15 strokes of a pre-chilled
pestle B homogenizer and the homogenates were centri-
fuged at 25,000 g for 30 min at 4°C. The supernatants
were further centrifuged at 25,000 g for 30 min at 4°C
and stored at -80°C for cytochrome-c analysis.
Western blotting
The HT29 cells (1.2·106) were treated with MA at IC50
and IC80 for 12, 24, 48 and 72 h, after which they were
washed twice with PBS and resuspended in lysis buffer
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EDTA, 1 mM EGTA, 1% Triton X-100, 1 mM ortovana-
date, 1 mM sodium glycerophosphate, 5 mM sodium
fluoride, 1 mM sodium pyrophosphate, 5 mM b-mer-
captoethanol, 1 mM bezamidine, 35 μg/mL PMSF, 5 μg/
mL leupeptine). The samples were homogenized ultraso-
nically and incubated on ice for 20 min before being
centrifuged at 12,000 g for 15 min. The supernatants
were assayed for protein concentration.
For western-blot analyses, a 25-50 μg sample of total
proteins was separated on 15% SDS-polyacrylamide gel
and transferred to a polyvinylidene difluoride mem-
brane. The membranes were blocked by incubation in
TBS buffer containing 0.1%T w e e n - 2 0a n d5 %d r i e d
milk for 1 h at room temperature and washed with TBS
buffer containing 0.1% Tween-20. They were then
blotted overnight at 4°C with primary antibodies [rabbit
polyclonal anti-caspase-3 and -9 (1/1000 dilution) and
mouse monoclonal anti-JNK (1/500 dilution), rabbit
anti-caspase-7 and anti-Bid (1/3000 dilution), rabbit
anti-Bax and mouse monoclonal anti-Bcl-2 (1/500 dilu-
tion), mouse monoclonal anti-p53 (1/200 dilution)]. To
determine caspase-8, membranes were blotted for 1 h at
25°C with a rabbit polyclonal primary antibody anti-cas-
pase-8 (1/3000). The blots were washed 3 times with
TBS-0.1% Tween and developed with peroxidase-linked
secondary antibodies (1/3000). For cytochrome-c deter-
mination, membranes were blotted for 1 h at 25°C with
a mouse monoclonal primary antibody anti-cytochrome-
c (1/3000). All blots were developed by ECL Western
Blotting Detection Kit Reagent and detected using a
LAS-3000 imaging system.
Statistics
Data are given as the means ± SEM. For each assay Stu-
dent’s t-test was used for statistical comparison with the
untreated control cells. A limit of p ≤ 0.05 was accepted
for significant differences.
Results
Single-cell gel electrophoresis (comet assay)
We determined DNA integrity in single cells by the
comet assay (Figure 1A). The results indicated that MA
interfered with DNA integrity in HT29 cells. To verify
the sensitivity and reliability of the comet assay in
detecting DNA damage we conducted tests that showed
that treatment of cells by peroxide or MMS produced a
significant increase in the tail moment (data not shown).
Three incubation times (24, 48 and 72 h) and two con-
centrations of MA (IC50 and IC80) were tested to deter-
mine clastogenic effects (Figure 1B). HT29 cells treated
with MA showed no significant increase in clastogenic
effects after 24 h (only 18% at IC50). After 48 h at IC50,
however, these values increased almost 6-fold. At IC80 a
lesser increase in the tail moment was observed at all
treatment times, with no effect after 24 h, 28% after 48
h and 69% after 72 h, probably due to the cytotoxic
effect induced by maslinic acid under these conditions.
Flow cytometric analysis
In the light of the inhibition of cell growth caused by
MA reported by [18] we investigated its effects on cell-
cycle distribution. The proliferation and proportions of
cells in different phases of the cell cycle were analyzed
at 72 and 96 h by the incorporation of PI. DNA histo-
gram analysis revealed that MA induced a concentra-
tion-dependent increase in the number of cells within
the G0/G1 phase with a maximum at IC80 (21.4 ±
6.0%). This increase was accompanied by a decrease in
the percentage of proliferating cells (17.7 ± 5.4% in
phase S plus 3.3 ± 1.4% in phase G2/M) (Figure 1C). At
IC50 the increase in cells in the G0/G1 phase was 12.5
± 5.1%, and the decrease in phase S was 9.4 ± 4.4% and
3.7 ± 1.1% in phase G2/M. This concentration-depen-
dent increase in the G0/G1 phase can also be seen in
the increase in the central population of FS/SS.
Flow cytometry after PI staining allows cell-cycle ana-
lysis, and any cells undergoing apoptosis can be detected
as a subdiploid peak. The results revealed that after 96 h
of IC80 maslinic treatment, the population of HT29
cells detected in the sub G0/G1 peak increased substan-
tially (Figure 1D). At IC80 the hypodiploid region
included 15% of total events. In this case the appearance
of a population of cell fragments in the sub-G0/G1
phase was evident both at IC50 and IC80, a result that
could clearly be seen in the FS/SS analysis.
Maslinic acid induces the expression of JNK and p53
Therapeutic agents trigger apoptosis via the activation of
stress-related signaling pathways including p53 and
JNK-mediated ones and so we examined the possibility
that MA might activate the JNK pathway. We found
that MA did indeed induce an apoptotic mitochondrial
activation via JNK, including cleavage of Bid and the
mitochondrial translocation of Bax and Bcl-2 inhibition.
JNK activation was determined by western blotting at
12, 24, 48 and 72 h. The results showed that MA highly
induces the activation of JNK in HT29 cells.
As shown in Figure 2A, JNK induction increased con-
comitantly with dosage and incubation time, beginning
after 12 hours’ treatment at both concentrations of IC50
and IC80. A relative maximum level of JNK expression
was reached after 12 h at IC80 (2.5-fold). The maximum
levels of JNK expression were reached after 72 h at
IC80 and IC50 (4-fold at IC80 and 2.6-fold at IC50). It
appears that the JNK pathway is induced 12 h after the
cells are exposed to MA, followed by the transcription
of p53 between 12 and 24 h and then the activation of
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appearance of apoptotic bodies at 96 h. Thus the trig-
gering of the JNK pathway is an early event in the apop-
totic chain and its activation plays a central role in the
up-regulation of apoptosis exerted by maslinic acid.
Activation of the p53 signal pathway in HT29 cells
after treatment with MA was tested by western blotting
(Figure 2B) at 12, 24, 48 and 72 h. A dose- and time-
dependent increase in p53 expression was detected,
beginning after 12 hours’ t r e a t m e n ta tb o t hI C 5 0a n d
IC80. The maximum level of JNK expression (9-fold
increase) was reached after 72 h at IC80. At this con-
centration the level of p53 increased 3-fold after 24 h
and remained constant until the end of incubation. It is
well established that the tumor-suppressor protein p53
controls cell growth through cell-cycle arrest and the
induction of apoptosis [24]. It regulates different genes,
such as p21 for the cell cycle and Bax for apoptosis [25].
This may well explain the cell cycle observed in
response to MA treatment. Several authors have shown
that the transcription of p53 brings about an accumula-
tion of apoptotic cells in the G1 cell-cycle phase [26].
Maslinic acid activates Bid and Bax and inhibits Bcl-2
JNK and p53 stimulate the mitochondrial apoptotic
pathway, thus enabling direct protein-interaction-based
activation or inhibition of the Bcl-2 protein family. JNK
and p53 can also induce the pro-apoptotic Bcl-2 pro-
teins by transcription or inhibit the transcription of
anti-apoptotic Bcl-2 proteins. We examined the effect of
MA on the expression of the Bcl-2 protein group. The
proteins studied were the Bcl-2 anti-apoptotic protein
Figure 1 (Panel A) Comet assay images of HT29 cells treated with maslinic acid after 24, 48 and 72 h at concentrations of IC50 and
IC80. An increase in the tail moment can be seen after 48 hours’ treatment at IC50. (Panel B) Tail-moment values observed in HT29 cells treated
with maslinic acid at concentrations of IC50 and IC80 after 24, 48 and 72 h. Percentages compared to untreated control cells are also shown. The
values represent means ± SD of four separate experiments. (Panel C) Histograms of cell cycle of HT29 cells after 72 hours’ treatment with
maslinic acid. Diagram of forward scatter (FS) versus side scatter (SS) of HT29 cells. It can be seen that the central population corresponding to
cells in the G0/G1 cell cycle phase was increased. (Panel D) Histograms of cell cycle of HT29 cells after 96 hours’ treatment with maslinic acid. A
hypodiploid peak can be seen in the sub-G0/G1 region. Diagram of FS versus SS of HT29 cells. Sub-G0/G1 populations are seen to appear at
both IC50 and IC80. Values represent means of three separate experiments. Significances are represented as (*) P < 0.05, and (**) P < 0.01.
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Page 5 of 13Bcl-2 (48, 72 h), the Bcl-2 pro-apoptotic protein Bax
(48, 72 h), and the Bcl-2 pro-apoptotic BH3 single-
domain protein Bid (12, 24, 48 and 72 h).
Two different active fragments of Bid have been
described: truncated Bid, or t-Bid, [27] and j-Bid [3].
Because these fragments are very small they remained
undetected in the western blotting of this protein.
Nevertheless, a decrease in the Bid-complete levels was
detected in response to MA (Figure 2C). After 24 h this
decrease was evident at both IC50 (32%) and IC80
(51%). The minimum level of Bid was reached after 48 h
(56% at IC50 and 84% at IC80). These decreases
remained until the end of treatment (48% at IC50 and
60% at IC80).
A cleaved form of Bid translocates to the outer mito-
chondrial membrane and promotes the oligomerization
of Bax. Bcl-2 inhibition has also been reported in
response to the mitochondrial translocation of cleaved
Bid [27]. As the maximum levels of response to MA
with regard to cell-cycle arrest and the stimulation of
apoptosis were observed after 72 h we decided to ana-
lyse the expression of Bax and Bcl-2 after 24, 48 and 72
hours’ treatment at both concentrations.
The results showed a dose-dependent increase in Bax
expression over time (Figure 3A) and a concomitant
decrease in the expression of Bcl-2 (Figure 3B). The
maximum levels of Bax were reached at the end of incu-
bation (6.5-fold at IC50 and 8.5-fold at IC80) (Figure
3B). As for Bcl-2, there was a marked decrease from 48
h to minimums of 55% at IC50 and 87% at IC80. These
levels later increased somewhat but always remained
lower than in the control cells until the end of the assay
at 72 h (35% at IC50 and 23% at IC80). Both Bax activa-
tion and Bcl-2 inhibition are required for the release of
mitochondrial apoptotic factors and the activation of the
intrinsic apoptotic route.
Figure 2 Western blottings of the levels of JNK (panel A), p53 (panel B) and Bid (panel C) proteins. HT29 cells were treated with maslinic
acid at concentrations of IC50 and IC80 for 12, 24, 48 and 72 h. The levels of protein expression are expressed as arbitrary intensity units of each
band compared to arbitrary intensity units of actin. The variations in relative percentages of the expression of proteins for each time and
concentration are also shown. The values represent means ± SD of at least three separate experiments.
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Page 6 of 13Figure 3 Western blottings of the levels of Bax (panel A), Bcl-2 (panel B) and cytochrome-c (panel C) proteins. HT29 cells were treated
with maslinic acid at concentrations of IC50 and IC80 for 48 and 72 h. The levels of protein expression are expressed as arbitrary intensity units of
each band compared to arbitrary intensity units of actin. The variations in relative percentages of the expression of Bax, Bcl-2 and cytochrome-c
for each time and concentration are also shown. The values represent means ± SD of at least three separate experiments.
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Page 7 of 13Maslinic acid induces the release of cytochrome-c and the
activation of caspases
The activation of pro-apoptotic Bcl-2 proteins and inhi-
bition of the anti-apoptotic Bcl-2 protein facilitate the
release of cytochrome-c and other apoptogenic proteins
from the intermembrane space of the mitochondria into
the cytosol. Cytochrome-c, released in the presence of
(d)ATP, binds to and activates the adaptor protein
Apaf-1, which in turn recruits caspase-9, leading to the
formation of apoptosome, the activation of caspase-9
and subsequent activation of executioner caspases -3
and -7 [28].
Here we have studied this effect after longer incuba-
tion times and at higher MA concentrations to find out
more about its prolonged effect. Cytochrome-c levels
were measured after 48 and 72 h at IC50 and IC80. The
results showed that the release of cytochrome-c was
both time- and dose-dependent, maximum levels being
reached after 72 h at IC80 (Figure 3C).
With regard to caspase activation, we looked at the
expression levels of executor caspases -3 and -7, and
initiator caspases -8 and -9. After 48 h caspase-9 was
completely activated (3-fold at IC50 and 4-fold at IC80)
(Figure 4A). This activation reached maximum activity
after 72 h. The maximum levels of caspase-3 were
reached after 72 h (5-fold at IC50 and 10-fold at IC80)
(Figures 4B). Coinciding with maximum caspase-3 acti-
vation, we observed a significant activation of caspase-7
(20-fold at IC50 and 40-fold at IC80) (Figures 4C).
Finally, we observed a belated increase in the expres-
sion of caspase-8. The late activation of this protease
has been described in several mitochondrial-mediated
apoptotic mechanisms [29]. Our results showed clear
activation of caspase-8 (8-fold) at the end of treatment
at IC80 (Figure 4D). This belated caspase-8 activation
may serve to amplify the initial mitochondrial apoptotic
signaling via the JNK pathway. All these changes in cas-
pase signaling explain the apoptotic phenomenon
observed in the HT29 cell line in response to maslinic
acid.
Discussion
A p o p t o s i si so n eo ft h eb o d y ’s most potent defences
against cancer; the pathogenesis of many forms of this
degenerative disease is closely connected with aberrantly
regulated apoptotic cell death. Different mechanisms
that regulate apoptosis associated with mediators that
trigger or inhibit cell death have led to the development
of therapeutic strategies against cancer. It is now known
that various triterpenes are able to intervene in such
processes as DNA repair, cell proliferation, cell differen-
tiation, angiogenesis and apoptosis [18,20,30]. Whilst in
previous studies we have demonstrated clearly that
maslinic acid did not affect the apoptosis of normal cells
[18] we are able to propose here a plausible molecular
mechanism by which this triterpene might induce its
anti-tumoral and pro-apoptotic effects upon HT29
colon-cancer cells.
We have shown that a sequential pathway involving
JNK, p53, the Bcl-2 protein family and caspase is acti-
vated in synchrony during the time in which MA med-
iates apoptosis. The pro-apoptotic JNK cascade induces
apoptosis via the mitochondria-dependent pathway. The
JNK-induced activation of the mitochondrial apoptosis
pathway is not a secondary consequence of caspase acti-
vation, which proves the hypothesis that JNK is involved
in the activation of the intrinsic mitochondrial apoptotic
pathway [31]. We found a marked and significant
increase in JNK expression (2.5-fold at 12 h) from the
beginning of treatment with MA. The main result sup-
porting our hypothesis is the induction of JNK before
caspase-8 is activated and apoptosis occurs. This early
induction of JNK may explain the activation of p53 and
mitochondrial apoptosis mediated by the Bcl-2 protein
family triggered by maslinic acid.
The function of p53 is also regulated by JNK phos-
phorylation [11]. In response to MA treatment, p53 was
induced in a time- and dose-dependent way, reaching its
maximum level after 72 h (9-fold increase). Several
authors have reported that p53 controls cell-cycle arrest
and apoptosis induction by regulating the expression of
different proteins such as p21, Bax and Bcl-2 [32,33].
Other authors have described p53 expression in
response to genotoxicity [34,35]. For these reasons we
are confident in our assertion that the effects of MA
upon HT29 cells are mediated in part by the expression
of p53.
The over-expression of p53 in HT29 cells could well
explain cell-cycle arrest, cell differentiation and the late
induction of genotoxicity. Our results show that MA
can induce apoptosis and cell-cycle arrest in this cancer
cell line in a dose-dependent way. We found that the
cell-cycle was arrested by 22% with IC80 and 18% with
IC50. Genotoxicity was not significant until after 48
hours’ treatment (6-fold at IC50). This delay was related
to the behaviour of p53 activation. An analysis of the
cell cycle also revealed that treatment with MA brought
about the formation of apoptotic bodies. The apparition
of a hypodiploid peak is clear after 96 h at IC80.
Furthermore, the FS/SS graph shows the appearance of
cell fragments. Our results demonstrate that the apopto-
tic effect is mediated by the activation of the mitochon-
drial pathway.
It has also been shown that p53 itself translocates to
mitochondria, where it activates the mitochondrial
apoptotic pathway by binding to the anti-apoptotic
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Page 8 of 13Figure 4 Western blottings of the levels of pro- and caspase-9 (panel A), pro- and caspase-3 (panel B), pro- and caspase-7 (panel C),
and pro- and caspase-8 (panel D) proteins. HT29 cells were treated with maslinic acid at concentrations of IC50 and IC80 for 48 and 72 h. The
levels of protein expression are expressed as arbitrary intensity units of each band compared to arbitrary intensity units of actin. The variations in
relative percentages of the expression of proteins for each time and concentration are also represented in this figure. The values represent
means ± SD of at least three independent experiments.
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Page 9 of 13proteins Bcl-2 and Bcl-xL [33]. An accumulation of p53
in the cytosol can act in a similar way to BH3-only pro-
teins, thus inducing the oligomerization of Bax [32].
Finally, p53 leads to the expression of pro-apoptotic
proteins, including members of the BH3-only group of
Bcl2-related proteins such as Bid, which can trigger the
mitochondrial apoptotic pathway [36]. Anti-apoptotic
proteins such as Bcl-2 have been reported to be phos-
phorylated and inactivated by JNK. In addition, it has
also been reported that the activation of JNK-mediated
Bid produces the active fragment j-Bid [3], whereas pro-
apoptotic Bax is not activated in JNK-deficient cells [6].
We have also identified the Bcl-2 proteins involved in
maslinic-acid-induced apoptosis.
Members of the three subfamilies of Bcl-2 proteins are
involved in the stimulation of apoptosis by MA. We
observed a decrease in the time- and dose-dependence
of Bid-complete levels, reaching 84% at IC80 after 48 h.
Bax activation also reached its maximum after 72 h
(8.5-fold at IC80). Finally, Bcl-2 inhibition was obvious
after 48 hours’ treatment (87% at IC80). These data
show that mitochondrial apoptosis is activated by MA,
probably in response to the induction of JNK and p53,
all of which leads to the levels of mitochondrial cyto-
chrome-c remaining high until 72 hours’ treatment at
both IC50 and IC80.
Other triterpenoids such as ursolic acid, CDDO and
b e t u l i n i ca c i dh a v eb e e nr e p orted to stimulate similar
apoptotic mechanisms. Ursolic acid induces apoptosis
via the mitochondrial intrinsic pathway with alterations
of the Bax/Bcl-2 balance in M4Beu cells [37] and its
anti-carcinogenic properties have also been described
[38]. Another triterpene, CDDO, which triggers the
cleavage of Bid and the release of mitochondrial cyto-
chrome-c, is blocked by the over-expression of Bcl-xL
or Bcl-2 [22,39]. It has also been reported that CDDO
stimulates JNK, the activation of caspase-8, loss of
mitochondrial transmembrane potential, release of
cytochrome-c and cleavage of caspase-3 [20]. Finally,
CDDO up-regulates p21 and down-regulates cyclin D1
and Bcl-2, thus inducing cell-cycle arrest and apoptosis
in MDA-MB-435 tumor cells [40]. CDDO-Me rapidly
activates the JNK apoptosis pathway, whereas the
action of a JNK-specific inhibitor blocks CDDO-Me
induced apoptosis [21]. This synthetic triterpenoid
does not alter the expression levels of Bcl-2 and Bcl-xL
but does raise Bax expression levels [41], leading to the
suppression of the expression of NF-kB-regulated gene
products [42].
The induction of apoptosis by betulinic acid involves
several mitochondrial perturbations, such as the release
of cytochrome-c and activation of caspase-8 [43].
Furthermore, it has been reported that the protein Smac
is released during the induction of apoptosis by betulinic
acid, whereas with other tumoral cells it provokes the
down-expression of Bcl-2, thus blocking the release of
anti-apoptogenic molecules [44]. In addition, the forma-
tion of reactive oxygen species that modulate Bcl-2 and
Bax levels during the action of betulinic acid has also
been detected [45].
Other terpenoids, such as amooranin for example,
induce apoptosis in MDA-468 cells via the activation of
caspases -9, -3, and -8, the cleavage of Bid and the
release of cytochrome-c from the mitochondria, conco-
mitant with the up-regulation of p53 and Bax and
down-regulation of Bcl-2 [46]. In addition, an increase
in the Bax/Bcl-2 ratio and a decrease in mitochondrial
membrane potential have been reported as being
involved in the induction of apoptosis for alisol B acet-
ate [47].
Conclusions
Our own results show that treating HT29 adenocarci-
noma cells with MA causes cascade signaling in the
i n d u c t i o no fc a s p a s e s ,w h i c hi nt u r ng o v e r n st h e
mechanisms for inducing apoptosis. Initiator caspase-9
and executor caspase-3 were activated significantly after
48 h, reaching their maximum levels after 72 h., The
initiator caspase-8 and executor caspase-7, on the other
hand, were not activated until 72 h. This belated activa-
tion of caspase-8 is almost certainly related to the
strengthening and consequent amplification of the initial
mitochondrial apoptotic signaling.
According to these results we propose the following
mechanism for the apoptotic effect of MA upon HT29
colon-cancer cells (Figure 5). Initially MA induces both
JNK and p53, thus provoking cell-cycle arrest and at the
same time a delay in the induction of genotoxicity. Sub-
sequently, in response to this activation of JNK and p53,
the expression of the pro-apoptotic Bcl-2 proteins Bax
and Bid is enhanced whilst that of Bcl-2 is inhibited.
The apoptotic mitochondrial pathway is thus triggered,
producing mitochondrial disruption and the activation
of caspase-9, which finally leads to the activation of cas-
pases -3, -8 and -7. Further studies inhibiting these
routes in different colon-cancer cell types will be needed
to confirm the proposed mechanism and justify its gen-
eral validity.
The apoptotic potency of MA suggests that it may be
an effective compound in therapy for the treatment of
colon cancer. Within this context, our most recent
results with APC-min mice, animals with a positive can-
cer-colon phenotype (data not shown), have shown a
considerable decrease in the number, development and
extension of tumors in the animals treated with maslinic
acid.
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Page 10 of 13Figure 5 Schematic representation of the plausible molecular mechanism proposed for the induction of apoptosis by maslinic acid in
HT29 colon-cancer cells. This molecular mechanism is regulated via the induction of JNK and p53, resulting in mitochondrial disruption, the
release of cytochrome-c and finally the activation of a cascade of caspases.
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